Mathematically modelling and controlling prostate cancer under intermittent hormone therapy

Asian Journal of Andrology

Volumn 14, Issue 2, 2012, Pages 270-277

  Hirata, Yoshito ^a   Tanaka, Gouhei ^a   Bruchovsky, Nicholas ^b   Aihara, Kazuyuki ^a  

^a INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

diagnosis; intermittent androgen suppression; mathematical models; personalized treatment schedule; prognosis; prostate cancer

Indexed keywords

CANCER CELL; CANCER CONTROL; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; INTERMITTENT ANDROGEN SUPPRESSION; MATHEMATICAL MODEL; PARTIAL DIFFERENTIAL EQUATIONS MODEL; PIECEWISE LINEAR MODEL; PROSTATE CANCER; REVIEW; STOCHASTIC MODEL; TUMOR GROWTH;

ANDROGEN ANTAGONISTS; CELL PROLIFERATION; DRUG ADMINISTRATION SCHEDULE; HUMANS; INCIDENCE; MALE; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS;

EID: 84858066798     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.155     Document Type: Review

References (22)

1. Huggins C, Hodges CV. Studies on prostate cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7.
2. Akakura K. Intermittent Endocrine Therapy for Prostate Cancer. Tokyo: Medical View; 2005. Japanese.
3. Noble RL. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res 1977; 37: 82-94. (Pubitemid 8009280)
4. Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, ToMet al. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res 1990; 50: 2275-82. (Pubitemid 20134481)
5. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR et al. Effects of intermittent androgen suppression on androgen-dependent tumors: apoptosis and serum prostate-specific antigen. Cancer 1993; 71: 2782-90. (Pubitemid 23120055)
6. Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010; 57: 49-59.
7. Jackson TL. A mathematical investigation of the multiple pathways to recurrent prostate cancer: comparison with experimental data. Neoplasia 2004; 6: 679-704.
8. Jackson TL. A mathematical model of prostate tumor growth and androgenindependent relapse. Disc Cont Dyn Syst-Ser. B 2004; 4: 187-201. (Pubitemid 38202961)
9. Ideta AM, Tanaka G, Takeuchi T, Aihara K. A mathematical model of intermittent androgen suppression for prostate cancer. J Nonlinear Sci 2008; 18: 593-614.
10. Tanaka G, Tsumoto K, Tsuji S, Aihara K. Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer. Physica D 2008; 237: 2616-27.
11. Tanaka G, Tsuji S, Aihara K. Grazing-induced crises in hybrid dynamical systems. Phys Lett A 2009; 373: 3134-9.
12. Guo Q, Tao Y, Aihara K. Mathematical modelling of prostate tumor growth under intermittent androgen suppression with partial differential equations. Int J Bifurcat Chaos 2008; 18: 3789-97.
13. Tao Y, Guo Q, Aihara K. A model at the macroscopic scale of prostate tumor growth under intermittent androgen suppression. Math Mod Meth Appl Sci 2009; 19: 2177-201.
14. Tao Y, Guo Q, Aihara K. A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor. J Nonlinear Sci 2010; 20: 219-40.
15. Kokontis JM, Hay N, Liao S. Progression to LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 1998; 12: 941-53. (Pubitemid 30660662)
16. Hirata Y, Bruchovsky N, Aihara K. Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer. J Theor Biol 2010; 264: 517-27.
17. Shimada T, Aihara K. A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer. Math Biosci 2008; 214: 134-9.
18. Tanaka G, Hirata Y, Goldenberg SL, Bruchovsky N, Aihara K. Mathematical modeling of prostate cancer growth and its application to hormone therapy. Philos Trans R Soc A 2010; 368: 5029-44.
19. Bruchovsky N, Klotz L, Crook J, Malone S, Ludgate C et al. Final results of the Canadian Prospective Phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parameters. Cancer 2006; 107: 389-95. (Pubitemid 44036569)
20. Bruchovsky N, Klotz L, Crook J, Goldenberg SL. Locally advanced prostate cancer: biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy. Cancer 2007; 109: 858-67. (Pubitemid 46333527)
21. Suzuki T, Bruchovsky N, Aihara K. Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer. Philos Trans R Soc A 2010; 368: 5045-59.
22. Hirata Y, di Bernardo M, Bruchovsky N, Aihara K. Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer. Chaos 2010; 20: 045125.